Table 4 Clinical and molecular features of the 11 patients with Panton-Valentine leucocidin-positive MSSA isolates
Age range (years) | Gender | IP/OP | Underlying diseases | Diagnosis | Onset Group | Outcome | PFGE | MLST-spa |
|---|---|---|---|---|---|---|---|---|
5–10 | F | OP | None | Primary bacteremia | CA | Uneventfully | CT | ST1301-t8940 |
< 1 | M | IP | None | SSTI | CA | Uneventfully | AI | ST8-t008 |
5–10 | M | OP | None | SSTI | CA | Uneventfully | D | .. |
> 10 | F | IP | None | SSTI | CA | Uneventfully | D | ST59-t1950 |
5–10 | M | OP | None | SSTI | CA | Uneventfully | D | .. |
1–4 | M | IP | None | SSTI | CA | Uneventfully | D | .. |
> 10 | M | OP | Atopic | SSTI | CA | Uneventfully | D | ST59-t437 |
> 10 | M | OP | None | SSTI | HACO | Uneventfully | D | .. |
< 1 | M | IP | Preterm, Cardiovascular disease | Pneumonia | HO | Non-attributable mortality | D | .. |
5–10 | F | IP | None | SSTI | HO | Uneventfully | D | .. |
< 1 | F | IP | None | SSTI | HO | Uneventfully | D | .. |